A CRUK phase I/IIA, first in human dose‐escalation and expansion trial of HMBD‐001 (an anti‐HER3 antibody) in patients with advanced HER3 positive solid tumours

A CRUK phase I/IIA, first in human dose‐escalation and
expansion trial of HMBD‐001 (an anti‐HER3 antibody) in patients
with advanced HER3 positive solid tumours

Leave a Reply